Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Hermes Florez"'
Autor:
Juliana Ferri-Guerra, Raquel Aparicio-Ugarriza, Y. Nadeem Mohammed, Otoniel Ysea, Hermes Florez, Jorge G. Ruiz
Publikováno v:
Southern medical journal. 115(3)
To determine whether metformin is associated with reduced all-cause mortality in older adults with diabetes mellitus as compared with insulin or sulfonylureas, and to evaluate whether the metformin cumulative exposure followed a dose-response relatio
Autor:
Jill P. Crandall, Andrea M. Kriska, Sherita Hill Golden, Hermes Florez, Helen P. Hazuda, José A. Luchsinger, Qing Pan, Elizabeth M. Venditti, George A. Bray
Publikováno v:
J Gerontol A Biol Sci Med Sci
Background Frailty is a geriatric syndrome of decreased physiologic reserve and resistance to stressors that results in increased vulnerability to adverse health outcomes with aging. Diabetes and hyperglycemia are established risk factors for frailty
Autor:
Kristina M. Utzschneider, Naji Younes, Sahar Z Zangeneh, Mary L. Johnson, Erica V. Gonzalez, Ashok Balasubramanyam, Robert M. Cohen, Ali Shojaie, Christiane S. Hampe, Mary E. Larkin, Neda Rasouli, Steven E. Kahn, Kieren J. Mather, Barbara Brooks-Worrell, Jean Y. Park, Hermes Florez, Brenda M. Palomino, Cyrus Desouza, Jerry P. Palmer, Willy Marcos Valencia
Publikováno v:
Diabetes. 69
We hypothesized that islet autoimmunity, hitherto considered the pathophysiologic basis of type 1 diabetes (T1D) and latent autoimmune diabetes of adults (LADA), could contribute to ß cell dysfunction in patients with type 2 diabetes (T2D). To evalu
Autor:
Juliana Ferri-Guerra, Dhanya Baskaran, Raneem Milyani, Raquel Aparicio-Ugarriza, Hermes Florez, Jorge G. Ruiz
Publikováno v:
Gerontology and Geriatric Medicine
Gerontology and Geriatric Medicine, Vol 6 (2020)
Gerontology and Geriatric Medicine, Vol 6 (2020)
Frailty is a state of vulnerability to stressors resulting in higher morbidity, mortality, and utilization in older adults. Frailty and type 2 diabetes mellitus share similar pathophysiological mechanisms which metformin may target. The purpose of th
Autor:
Pravallika Bharatula, Juliana Ferri Guerra, Willy Marcos Valencia, Raquel Aparicio-Ugarriza, Jorge G. Ruiz, Raneem Milyani, Sriravali Potluri, Hermes Florez, Aakashi Shah
Publikováno v:
Diabetes. 68
Diabetes mellitus (DM) may promote accelerated aging fostering the development of frailty, a state of vulnerability to stressors resulting in higher morbidity, mortality and healthcare utilization, particularly among Veterans. Metformin may reduce th
Autor:
Christopher S. Piromalli, Andrea M. Kriska, Jill P. Crandall, Vanita R. Aroda, Qing Pan, Ann V. Schwartz, Hermes Florez, Marinella Temprosa
Publikováno v:
Diabetes. 67
Randomization to lifestyle intervention (ILS) or metformin (MET) in the Diabetes Prevention Program (DPP) resulted in weight loss and reduced progression to diabetes. The long term effects of these interventions on bone mineral density (BMD) and fall
Autor:
Chantal Underkofler, Heidi Krause-Steinrauf, Vanita R. Aroda, Hermes Florez, Sophia H. Hox, Deborah J. Wexler, Jill P. Crandall, Michael C. Backman, Alexander Kuhn
Publikováno v:
Diabetes. 67
GRADE is an NIDDK-sponsored, 36-center open-label randomized trial comparing the addition of one of the four most commonly used classes of glucose-lowering medications to metformin on long-term glycemic control and patient-centered outcomes in type 2
Autor:
Mathias Schlögl, Andrea M. Kriska, Rita R. Kalyani, Hermes Florez, William C. Knowler, Helen P. Hazuda, Mary A. Hoskin, Ann V. Schwartz, Qing Pan, Edward S. Horton
Publikováno v:
Diabetes. 67
Weight loss prevents progression to diabetes but long term effects on lean mass are unknown. We determined if intensive lifestyle modification (ILS), metformin (MET) or placebo (PLB) treatment in the Diabetes Prevention Program (DPP) had differential
Publikováno v:
Diabetologia. 60(9)
In a world where the population is ageing, there is growing interest and demand for research evaluating strategies that address the ageing process. After 60 years of successful use of metformin in our pharmaceutical armamentarium, we are learning tha
Autor:
Karol E. Watson, F. Xavier Pi-Sunyer, Hermes Florez, Jill P. Crandall, Yong Ma, Helen P. Hazuda, José A. Luchsinger, Susan Jeffries, Sherita Hill Golden, Elizabeth M. Venditti, Costas A. Christophi, Jennifer J. Manly
Publikováno v:
Diabetes Care
OBJECTIVE We examined the association of the Diabetes Prevention Program (DPP) intervention arms (lifestyle intervention, metformin, and placebo) with cognition in the Diabetes Prevention Program Outcomes Study (DPPOS). We also examined metformin use